This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the test product in healthy adult human subjects with dry or sensitive skin.
Age: 18 to 55 years (both inclusive) at the time of consent.
Sex: Healthy male and non-pregnant/non-lactating females.
Females of childbearing potential must have a self-reported negative pregnancy test.
Subject are generally in good health.
History of any dermatological condition of the skin diseases.
Subject with present condition of allergic response to any cosmetic product.
Subject having allergic response to the ink.
Presence of any broken, chapped, cut, irritated, or scraped skin at the application site.
Single group
Creanz Lotion
Other interventionMode of Usage: Apply sufficient quantity of Creanz Nourishing Body lotion to face and body for smooth and moisturised skin. Frequency: Twice a Day Route of Administration: Topical
Change in skin hydration
Instrumental Assessment: Corneometer CM 825
Change in skin elasticity
Instrumental Assessment: Cutometer Dual MPA 580
Change in Dry skin area and severity index
Dermatological assessment: 0 = Absent; 4 = Severe
Change in Overall Dry skin Score
Dermatological assessment: 0 = Absent; 4 = Dominated by large scales
Change in itchiness score
Dermatological Assessment: VAS score 0= no itch,10 = severe itch
change in visual assessment of skin dryness,
Dermatological Assessment: 0= absent,4 = Extreme
Change in visual assessment of skin smoothness,
Dermatological Assessment: 0= absent,4 = severe
Change in visual assessment of skin roughness,
Dermatological Assessment: 0= absent,4 = extreme
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
